Point Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Moonlake immunotherapeuticsArcutis biotherapeuticsZealand pharmaVerona pharmaBridgebio pharmaMohit bansalNeurocrine biosciencesIovance biotherapeuticsWells fargoAlnylam pharmaceuticalsRhythm pharmaceuticalsApellis pharmaceuticalsArrowhead pharmaceuticalsAmicus therapeuticsXenon pharmaceuticalsMadrigal pharmaceuticals

ASCO: J&J s radioligand spurs responses, but 4 deaths mar data

ASCO: J&J s radioligand spurs responses, but 4 deaths mar data
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesBristol myers squibbAmerican society of clinical oncologyFusion pharmaceuticalsEli lillyAmerican societyClinical oncologyPoint biopharmaAktis oncology

Eli Lilly and Aktis enter $1bn partnership to develop anticancer radiopharmaceuticals

Eli Lilly and Aktis enter $1bn partnership to develop anticancer radiopharmaceuticals
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Matthew rodenJacob van naardenEli lillyAktis oncologyVan naardenLilly oncologyPoint biopharma

Stocks poised to move as this corner of the cancer therapy market heats up

Radiopharmaceuticals seek to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly into the tumor.

New jerseyUnited statesBristol myers squibbEli lillyDan lyonsLouise chenWilliam blairPiper sandlerJeff jonesNovarti pluvictoAndy hsiehAndrew tsaiRoanna ruizEdward tenthoffGregory renzaLantheus holdings

This up-and-coming cancer treatment could be a $25 billion market opportunity — it s already a hotbed for M&A

Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.

New yorkUnited statesDan lyonsBristol rayzebioAndrew tsaiBristol myers squibbPiper sandler tenthoffJeff jonesGregory renzaJanus henderson lyonsPiper sandlerEli lillyWilliam blairEdward tenthoffMatt phippsFusion pharmaceuticals